Total Brain Limited (TTB)
20mins delayed
Movement
1 Year Return
Total Brain Limited Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $46.66 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
TTB Statistics
19 September
1,054 / 2,298
ASX Size Rank
1yr Return
vs Sector (1yr)
+33.06%
vs ASX 200 (1yr)
+38.38%
$46.66 million
Market Cap
Share Issue
777.69 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
19 September
N/A
PE Ratio
EPS ($)
-0.015
Earnings Yield
-24.17%
NTA ($)
0.01
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Total Brain Limited (TTB, formerly Brain Resource Limited) is developing and selling brain health products to consumers, corporates, clinicians and research. The Company currently provides two web products, Brain Training Platform and Clinical Decision Support, both of which are developed from the Company's platform, international Study to Predict Optimized Treatment (iSPOT). TTB has offices in San Francisco and Sydney and a global network of academics, scientists, researchers and universities.
Former Names
Brain Resource Company Limited (The), 07/05/2008; Brain Resource Limited (BRC), 30/11/2018
Upcoming Calendar
| 30 Sep 2019 | Report (Annual) |
| 27 Feb 2020 | Report (Interim) |
| 28 Aug 2020 | Report (Prelim) |
| 28 Aug 2020 | Report (Annual) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
TTB is not covered by a major broker.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Dr Evian Gordon | Executive Chairman, Executive Director | Aug 2000 |
|
| Mr Matthew (Matt) Morgan | Non-Executive Director | Mar 2016 |
|
| Mr Louis Gagnon | Chief Executive Officer, Managing Director | May 2017 |
|
| Mr Ajay Arora | Non-Executive Director | May 2018 |
|
| Mr David Torrible | Non-Executive Director | Jun 2019 |
|
| Mr Phillip Hains | Joint Company Secretary | Jul 2018 | |
| Mr Harvey Bui | Joint Company Secretary | Jul 2018 |
Director Transactions
TTB directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 16/05/19 | Matthew (Matt) Morgan | Buy | +296,429 | $0.028 | $8,300 | Off-market trade. |
| 12/02/19 | Matthew (Matt) Morgan | Buy | +315,111 | $0.027 | $8,557 | On-market trade. |
| 19/12/18 | Matthew (Matt) Morgan | Buy | +284,320 | $0.030 | $8,529 | On-market trade. |
| 16/11/18 | Matthew (Matt) Morgan | Buy | +134,219 | $0.035 | $4,697 | On-market trade. |
| 04/06/18 | Louis Gagnon | Buy | +2,035,000 | $0.040 | $80,475 | Off-market trade. |
| 14/03/18 | Matthew (Matt) Morgan | Buy | +175,675 | $0.050 | $8,814 | On-market trade. |
| 10/01/18 | Matthew (Matt) Morgan | Issued | 4,000,000 | $0.062 | $248,000 | Issue of options. |
| 10/01/18 | Louis Gagnon | Issued | 56,465,912 | $0.062 | $3,500,886 | Issue of options. |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 21 | 11 | 64 | 246 | 265 | 607 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Ltd. | 146,914,757 | 27.70% |
| HSBC Custody Nominees (Australia) Ltd GSCO | 56,439,634 | 10.60% |
| Buttonwood Nominees Pty Ltd. | 19,010,630 | 3.60% |
| Stuttgart Pty Ltd. | 17,604,735 | 3.30% |
| Morgan Stanley Australia Securities (Nominee) | 16,606,440 | 3.10% |
| CS Third Nominees Pty Ltd. | 12,956,480 | 2.40% |
| Dr. Evian Gordon | 11,240,248 | 2.10% |
| Gleneagle Securities (Aus) Pty Ltd. | 11,000,000 | 2.10% |
| DBPC Group Finance Pty Ltd. | 10,250,000 | 1.90% |
| UBS Nominees Pty Ltd. | 10,250,000 | 1.90% |
| JP Morgan Nominees Aaustralia Ltd. | 9,542,586 | 1.80% |
| Red Star Developments Pty Ltd. | 6,655,429 | 1.30% |
| Spinite Pty Ltd. | 5,500,000 | 1.00% |
| Mr. Dan Segal | 4,731,250 | 0.90% |
| Mr. Louis Gagnon | 4,159,225 | 0.80% |
| HSBC Custody Nominees (Australia) Ltd A/C 2 | 3,753,393 | 0.70% |
| Ceyx Holdings Pty Ltd. | 3,500,000 | 0.70% |
| Arch 2000 Management Pty Ltd. | 3,300,000 | 0.60% |
| Segal Super Pty Ltd. | 3,270,000 | 0.60% |
| Mr. David Yett | 3,190,394 | 0.60% |
| All other shareholders | 32.3 % | |
The Top 20 Shareholders of TTB hold 67.7% of shares on issue.
TTB Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
TTB Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: The provision of brain function analysis services.
Incorporated: in NSW on 08/08/2000. Name changed to Brain Resource Limited on 07/05/2008.
Suite 9, 89-97 Jones St
Ultimo NSW 2007
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.